Brain stimulation for the treatment of psychiatric disorders

Current Opinion in Psychiatry

Volumn 20, Issue 3, 2007, Pages 250-254

  George, Mark S ^a,b   Nahas, Ziad ^a   Borckardt, Jeffrey J ^a   Anderson, Berry ^a   Foust, Milton J ^a   Burns, Carol ^a   Kose, Samet ^a   Short, E Baron ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anticonvulsant; Antidepressant; Deep brain stimulation; Electroconvulsive therapy; Transcranial magnetic stimulation; Vagus nerve stimulation

Indexed keywords

LITHIUM; MORPHINE; NORTRIPTYLINE;

ALTERNATING CURRENT; BRAIN DEPTH STIMULATION; DEPRESSION; DIRECT CURRENT; ELECTROCONVULSIVE THERAPY; HAMILTON SCALE; HUMAN; MAGNETIC FIELD; MAJOR DEPRESSION; MENTAL DISEASE; PAIN; RELAPSE; REVIEW; SCHIZOPHRENIA; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; VAGUS NERVE STIMULATION;

BRAIN; DEEP BRAIN STIMULATION; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; HUMANS; MENTAL DISORDERS; PAIN; RANDOMIZED CONTROLLED TRIALS; SCHIZOPHRENIA; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; VAGUS NERVE;

EID: 34247167708     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3280ad4698     Document Type: Review

References (56)

1. ••].
2. Rush AJ, Trivedi MH, Wisniewski SR, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006; 354:1231-1242. This study, and the others emerging from this landmark STAR-D study, show that initial response rates to selective serotonin reuptake inhibitor antidepressants are not high, but that switching to other medications can boost response rates for an individual.
3. George MS, Belmaker RH. TMS in Clinical Psychiatry. Washington, DC: American Psychiatric Press; 2006.
4. Anderson B, Mishory A, Nahas Z, et al. Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J ECT 2006; 22:49-53.
5. Avery DH, Holtzheimer PE, Fawaz W, et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry 2006; 59:187-194.
6. Fitzgerald PB, Huntsman S, Gunewardene R, et al. A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression. Int J Neuropsychopharmacol 2006; 9:655-666.
7. Fitzgerald PB, Benitez J, de Castella A, et al. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatmentresistant depression. Am J Psychiatry 2006; 163:88-94.
8. Loo CK, Mitchell PB, McFarquhar TF, et al. A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression. Psychol Med 2007; 37:1-9.
9. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry; 2007. In press
10. O'Reardon JP, Blumner KH, Peshek AD, et al. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 2005; 66:1524-1528.
11. Fitzgerald PB, Benitez J, de Castella AR, et al. Naturalistic study of the use of transcranial magnetic stimulation in the treatment of depressive relapse. Aust NZ J Psychiatry 2006; 40:764-768.
12. Mishory A, Molnar C, Koola J, et al. The maximum-likelihood strategy for determining transcranial magnetic stimulation motor threshold, using parameter estimation by sequential testing is faster than conventional methods with similar precision. J ECT 2004; 20:160-165.
13. Taylor JL, Loo CK. Stimulus waveform influences the efficacy of repetitive transcranial magnetic stimulation. J Affect Disord 2007; 97:271-276.
14. Roth Y, Zangen A, Voller B, Hallett M. Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol 2005; 116:775-779.
15. Hoffman RE, Gueorguieva R, Hawkins KA, et al. Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry 2005; 58:97-104.
16. Jin Y, Potkin SG, Kemp AS, et al. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation ({alpha}TMS) on the negative symptoms of schizophrenia. Schizophrenia Bull 2006; 32:556-561.
17. Fitzgerald PB, Benitez J, Daskalakis JZ, et al. The treatment of recurring auditory hallucinations in schizophrenia with rTMS. World J Biol Psychiatry 2006; 7:119-122.
18. d'Alfonso AA, Aleman A, Kessels RP, et al. Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition. J Neuropsychiatry Clin Neurosci 2002; 14:77-79.
19. Rollnik JD, Huber TJ, Mogk H, et al. High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. NeuroReport 2000; 11:4013-4015.
20. Hoffman RE, Boutros NN, Hu S, et al. Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet 2000; 355:1073-1075.
21. Hoffman R, Boutros N, Berman R, et al. Transcranial magnetic stimulation and hallucinated 'voices'. Biol Psychiatry 1998; 43 (Suppl 1):S93s.
22. Andre-Obadia N, Peyron R, Mertens P, et al. Transcranial magnetic stimulation for pain control. Double-blind study of different frequencies against placebo, and correlation with motor cortex stimulation efficacy. Clin Neurophysiol 2006; 117:1536-1544.
23. Lefaucheur JP. Transcranial magnetic stimulation in the management of pain. Suppl Clin Neurophysiol 2004; 57:737-748.
24. Rollnik JD, Wustefeld S, Dauper J, et al. Repetitive transcranial magnetic stimulation for the treatment of chronic pain - a pilot study. Eur Neurol 2002; 48:6-10.
25. Lefaucheur JP, Drouot X, Nguyen JP. Interventional neurophysiology for pain control: duration of pain relief following repetitive transcranial magnetic stimulation of the motor cortex. Neurophysiol Clin 2001; 31:247-252.
26. Pridmore S, Oberoi G. Transcranial magnetic stimulation applications and potential use in chronic pain: studies in waiting. J Neurol Sci 2000; 182: 1-4.
27. Johnson S, Summers J, Pridmore S. Changes to somatosensory detection and pain thresholds following high frequency repetitive TMS of the motor cortex in individuals suffering from chronic pain. Pain 2006; 123:187-192.
28. Sampson SM, Rome JD, Rummans TA. Slow-frequency rTMS reduces fibromyalgia pain. Pain Med 2006; 7:115-118.
29. Borckardt JJ, Weinstein M, Reeves ST, et al. Post-operative left prefrontal repetitive transcranial magnetic stimulation (rTMS) reduces patient-controlled analgesia use. Anesthesiology 2006; 105:557-562.
30. Paulus W. Transcranial direct current stimulation (tDCS). Suppl Clin Neurophysiol 2003; 56:249-254.
31. Antal A, Nitsche MA, Paulus W. Transcranial direct current stimulation and the visual cortex. Brain Res Bull 2006; 68:459-463.
32. Fregni F, Boggio PS, Lima MC, et al. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury [see Comment]. Pain 2006; 122:197-209.
33. Fregni F, Boggio PS, Nitsche MA, et al. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord 2006; 8:203-204.
34. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006; 63:1337-1344.
35. Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005; 58:347-354.
36. Nahas Z, Marangell LB, Husain MM, et al. Two-year outcome of vagus nerve stimulation (VNS) therapy for major depressive episodes. J Clin Psychiatry 2005; 66:1097-1104.
37. George MS, Rush AJ, Marangell LB, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005; 58:364-373.
38. Sackeim HA, Brannan SK, Rush AJ, et al. Durability of antidepressant response to VNS. Int J Neuropsychopharmacol; 2007. In press
39. Dunner DL, Rush AJ, Russell JM, et al. Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psychiatry 2006; 67:688-695.
40. Corcoran CD, Thomas P, Phillips J, O'Keane V. Vagus nerve stimulation in chronic treatment resistant depression - preliminary findings of an open-label study. Br J Psychiatry 2006; 189:282-283.
41. Ness TJ, Fillingim RB, Randich A, et al. Low intensity vagal nerve stimulation lowers human thermal pain thresholds. Pain 2000; 86:81-85.
42. Kirchner A, Birklein F, Stefan H, Handwerker HO. Left vagus nerve stimulation suppresses experimentally induced pain. Neurology 2000; 55:1167-1171.
43. Borckardt JJ, Anderson B, Kozel FA, et al. Acute and long-term VNS effects on pain perception in a case of treatment-resistant depression. Neurocase 2006; 12:216-220.
44. Borckardt JJ, Kozel FA, Anderson B, et al. Vagus nerve stimulation affects pain perception in depressed adults. Pain Res Manag 2005; 10:9-14.
45. Walker BR, Easton A, Gale K. Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia 1999; 40:1051-1057.
46. Dorr AE, Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Therapeut 2006; 318:890-898.
47. Nemeroff CB, Mayberg HS, Krahl SE, et al. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 2006; 31:1345-1355.
48. Nahas Z, Teneback C, Chae JH, et al. Serial vagus nerve stimulation functional MRI (VNS/fMRI) in treatment resistant depression. Neuropsychopharmacology; 2007. In press
49. Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156:675-682.
50. Lomarev M, Denslow S, Nahas Z, et al. Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency and/or dose dependent effects at rest and during a simple task. J Psychiatry Res 2002; 36:219-227.
51. Mu Q, Bohning DE, Nahas Z, et al. Acute vagus nerve stimulation using different pulse widths produces varying brain effects. Biol Psychiatry 2004; 55:816-825.
52. Benazzouz A, Hallett M. Mechanism of action of deep brain stimulation. Neurology 2000; 55:S13-S16.
53. Piasecki SD, Jefferson JW. Psychiatric complications of deep brain stimulation for Parkinson's disease. J Clin Psychiatry 2004; 65:845-849.
54. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatmentresistant depression. Neuron 2005; 45:651-660.
55. Grill WM, Snyder AN, Miocinovic S. Deep brain stimulation creates an informational lesion of the stimulated nucleus. Neuroreport 2004; 15:1137-1140.
56. Wei XF, Grill WM. Current density distributions, field distributions and impedance analysis of segmented deep brain stimulation electrodes. J Neural Engng 2005; 2:139-147.